Li Zhang, PhD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address550 16th Street, #6708
San Francisco CA 94158
Phone415-476-5339
Emailli.zhang@ucsf.edu
ORCID ORCID Icon0000-0001-9242-0763 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of FloridaPh.D.2006Department of Statistics
    NCI/NIHPredoctoral Fellow2005Division of Cancer Epidemiology and Genetics
    University of FloridaM.S.2003Department of Statistics
    Southeast University, ChinaB.S.1999Civil Engineering
    Collapse Awards and Honors
    NIH/NLM2022  - 2026R01 LM013763
    UCSF CTSI2022  - 2022CTSI Impact Award
    NIH/NCI2021  - 20241R21CA264381-01
    UCSF Prostate Cancer Program2021  - 2021Prostate Cancer Pilot Project Award
    UCSF CTSI2021  - 2021The Excellence Consultant Award
    American Statistical Association2021  - 2021Outstanding Service Award
    UCSF Academic Senate2019  - 2020Research Allocation Program Award
    UCSF CTSI2017  - 2018Consultation Services Training Grant
    Prostate Cancer Foundation2017  - 2020The Movember Foundation-Challenge Award
    UCSF Helen Diller Family Comprehensive Cancer Center2016  - 2017UCSF Global Oncology Pilot Project Award
    NCI and UCSF Helen Diller Family Comprehensive Cancer Center2016  - 2017UCSF Research Allocation Program Award
    Prostate Cancer Foundation2014  - 2017The Safeway Foundation-PCF Challenge Award – The NEXT Project: Network Enriched Crossover Trial
    Cleveland Clinic2012  - 2012Innovator Award - Genomic Biomarkers of Lung Cancer Risk
    University of Florida2005  - 2006Keene Dissertation Fellowship Award

    Collapse Overview 
    Collapse Overview
    Li Zhang is a Full Professor in the Department of Medicine and the Department of Epidemiology and Biostatistics. She is an associate member of UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC). Dr. Zhang has over fifteen years of experience applying statistical methods in medical research, including epidemiology studies, basic science studies, clinical trials design, and high-throughput sequencing data. Her statistical methodological research interests are cancer epidemiology and immunoinformatics, and she has more than 100 publications. Currently, Dr. Zhang serves on Global Action Plan 6 Project Steering Committee and UCSF site PI for the Movember Foundation and American Society of Clinical Oncology Career Development Award as a statistical reviewer.

    Collapse Research 
    Collapse Research Activities and Funding
    Development of advanced computational approaches for characterizing repertoire sequencing to unravel the mechanism of immune response to cancer immunotherapy
    NIH/NLM R01 LM013763Apr 1, 2022 - Nov 10, 2026
    Role: PI
    Computational approaches to unravel immune receptor sequencing for cancer immunotherapy
    NIH/NCI R21CA264381Sep 15, 2021 - Aug 31, 2023
    Role: PI
    Determinants of response to cancer immunotherapy
    NIH R35CA253175Aug 1, 2021 - Jul 31, 2028
    Role: Co-Investigator
    Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications
    NIH R01EB029429Jul 1, 2021 - Mar 31, 2025
    Role: Co-Investigator
    New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
    NIH R01AI161027Apr 20, 2021 - Mar 31, 2025
    Role: Co-Investigator
    Precision targeting of T cell cytotoxicity with PET
    NIH R01CA258297Mar 1, 2021 - Feb 28, 2026
    Role: Co-Investigator
    Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring
    NIH R01CA256740Dec 1, 2020 - Nov 30, 2025
    Role: Co-Investigator
    California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
    NIH U54CA242646Aug 1, 2019 - Jul 31, 2024
    Role: Co-Investigator
    Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients
    NIH U01CA232320Apr 11, 2019 - Mar 31, 2024
    Role: Co-Investigator
    Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring
    NIH R01CA215694Jun 1, 2017 - May 31, 2022
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment. Clin Cancer Res. 2024 May 02. Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE. PMID: 38695832.
      View in: PubMed   Mentions:    Fields:    
    2. Dysregulation of CD4+ and CD8+ resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis. J Immunother Cancer. 2024 Apr 19; 12(4). He JY, Kim YJ, Mennillo E, Rusu I, Bain J, Rao AA, Andersen C, Law K, Yang H, Tsui J, Shen A, Davidson B, Kushnoor D, Shi Y, Fan F, Cheung A, Zhang L, Fong L, Combes AJ, Pisco AO, Kattah MG, Oh DY. PMID: 38642938; PMCID: PMC11033653.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer Immunol Res. 2024 Apr 02; 12(4):453-461. Chang H, Marquez J, Chen BK, Kim DM, Cheng ML, Liu EV, Yang H, Zhang L, Sinha M, Cheung A, Kwek SS, Chow ED, Bridge M, Aggarwal RR, Friedlander TW, Small EJ, Anderson M, Fong L. PMID: 38276989; PMCID: PMC10993769.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center. Oncologist. 2024 Mar 04; 29(3):e351-e359. Keenan BP, Sibley A, Zhang L, Westring AF, Velazquez AI, Bank EM, Bergsland EK, Boreta L, Conroy P, Daras M, Hermiston M, Hsu G, Paris PL, Piawah S, Sinha S, Sosa JA, Tsang M, Venook AP, Wong M, Yom SS, Van Loon K. PMID: 37440206; PMCID: PMC10911925.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    5. CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma. Clin Cancer Res. 2024 03 01; 30(5):1009-1021. Wadhwa A, Wang S, Patiño-Escobar B, Bidkar AP, Bobba KN, Chan E, Meher N, Bidlingmaier S, Su Y, Dhrona S, Geng H, Sarin V, VanBrocklin HF, Wilson DM, He J, Zhang L, Steri V, Wong SW, Martin TG, Seo Y, Liu B, Wiita AP, Flavell RR. PMID: 38109209; PMCID: PMC10905524.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    6. Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. Theranostics. 2024; 14(4):1344-1360. Bobba KN, Bidkar AP, Wadhwa A, Meher N, Drona S, Sorlin AM, Bidlingmaier S, Zhang L, Wilson DM, Chan E, Greenland NY, Aggarwal R, VanBrocklin HF, He J, Chou J, Seo Y, Liu B, Flavell RR. PMID: 38389832; PMCID: PMC10879874.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    7. Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer. Cancer Res Commun. 2024 01 25; 4(1):200-212. Soto M, Filbert EL, Yang H, Starzinski S, Starzinski A, Gin M, Chen B, Le P, Li T, Bol B, Cheung A, Zhang L, Hsu FJ, Ko A, Fong L, Keenan BP. PMID: 38181044; PMCID: PMC10809910.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program. Res Sq. 2024 Jan 16. Lewis KA, Stroebel B, Zhang L, Aouizerat B, Mattis A, Flowers E. PMID: 38313262; PMCID: PMC10836103.
      View in: PubMed   Mentions:
    9. Electronic health record intervention to increase use of NSAIDs as analgesia for hospitalised patients: a cluster randomised controlled study. BMJ Health Care Inform. 2023 Dec 30; 30(1). Bongiovanni T, Pletcher MJ, Robinson A, Lancaster E, Zhang L, Behrends M, Wick E, Auerbach A. PMID: 38159932; PMCID: PMC10759061.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Survival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors. Endocr Relat Cancer. 2024 Jan 01; 31(1). Mulvey CK, Paciorek A, Moon F, Steiding P, Shih B, Gubens MA, Zhang L, Bergsland EK, Cheng I. PMID: 37882324; PMCID: PMC10762535.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Inflammatory Bowel Disease and the Risk of Anal Squamous Intraepithelial Lesions and Anal Cancer in Men Who Have Sex With Men. Inflamm Bowel Dis. 2023 Nov 10. Field J, Fenton C, Zhang L, Brickman C, Mahadevan U. PMID: 37951596.
      View in: PubMed   Mentions: 1     Fields:    
    12. The Decrease in Serum Total Cholesterol and Low-Density Lipoprotein (LDL) Concentrations With the Initiation of Hemodialysis Despite a Concomitant Increase in Serum Albumin Concentrations. Cureus. 2023 Oct; 15(10):e47272. Sam R, Zhang L, Tuot DS, Chaudhry R. PMID: 38022186; PMCID: PMC10655933.
      View in: PubMed   Mentions:
    13. Optimizing Uptake of Multimodal Pain Management After Surgery Using the Electronic Health Record. JAMA Surg. 2023 Oct 01; 158(10):1108-1111. Bongiovanni T, Lancaster E, Behrends M, Zhang L, Wick E, Auerbach A, Pletcher MJ. PMID: 37610736; PMCID: PMC10448375.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Feasibility and Clinical Acceptability of Automation-Assisted 3D Conformal Radiotherapy Planning for Patients With Cervical Cancer in a Resource-Constrained Setting. JCO Glob Oncol. 2023 09; 9:e2300050. Muya S, Ndumbalo J, Kutika Nyagabona S, Yusuf S, Rhee DJ, Mushi BP, Li B, Zhang L, Grover S, Feng M, Hsu IC, Mmbaga E, Van Loon K, Court L, Xu M. PMID: 37725767; PMCID: PMC10581615.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer. Cancer Res. 2023 08 15; 83(16):2763-2774. Lundberg A, Zhang M, Aggarwal R, Li H, Zhang L, Foye A, Sjöström M, Chou J, Chang K, Moreno-Rodriguez T, Shrestha R, Baskin A, Zhu X, Weinstein AS, Younger N, Alumkal JJ, Beer TM, Chi KN, Evans CP, Gleave M, Lara PN, Reiter RE, Rettig MB, Witte ON, Wyatt AW, Feng FY, Small EJ, Quigley DA. PMID: 37289025; PMCID: PMC10425725.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. MicroRNA biomarkers target genes and pathways associated with type 2 diabetes. Diabetes Res Clin Pract. 2023 Sep; 203:110868. Kariuki D, Aouizerat BE, Asam K, Kanaya AM, Zhang L, Florez JC, Flowers E. PMID: 37543292.
      View in: PubMed   Mentions: 1     Fields:    
    17. The Impact of the COVID-19 Shelter-in-Place Order on Traumatic Brain Injuries in San Francisco, California. J Emerg Med. 2023 12; 65(6):e479-e486. Madhok DY, Nardone A, Caceres EU, Wong AHK, Zhang L, Rodriguez RM. PMID: 37914599.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    18. Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies. Support Care Cancer. 2023 Jul 10; 31(8):453. Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA. PMID: 37428241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. NAIR: Network Analysis of Immune Repertoire. Front Immunol. 2023; 14:1181825. Yang H, Cham J, Neal BP, Fan Z, He T, Zhang L. PMID: 37614227; PMCID: PMC10443597.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    20. A behavioral intervention to promote use of multimodal pain medication for hospitalized patients: A randomized controlled trial. J Hosp Med. 2023 08; 18(8):685-692. Bongiovanni T, Pletcher MJ, Lau C, Robinson A, Lancaster E, Zhang L, Behrends M, Wick E, Auerbach A. PMID: 37357367; PMCID: PMC10578203.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas. Br J Cancer. 2023 08; 129(2):291-300. Raj N, Chan JA, Wang SJ, Aggarwal RR, Calabrese S, DeMore A, Fong L, Grabowsky J, Hope TA, Kolli KP, Mulvey CK, Munster PN, Perez K, Punn S, Reidy-Lagunes D, Von Fedak S, Zhang L, Bergsland EK. PMID: 37208512; PMCID: PMC10338510.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    22. Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin. Clin Genitourin Cancer. 2023 10; 21(5):e394-e404. Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal R, Small EJ, Fong L, Chou J, Friedlander T, de Kouchkovsky I, Koshkin VS. PMID: 37316414.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. MicroRNAs Associated With Incident Diabetes in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2023 05 17; 108(6):e306-e312. Flowers E, Aouizerat BE, Kanaya AM, Florez JC, Gong X, Zhang L. PMID: 36477577; PMCID: PMC10188307.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy. Clin Cancer Res. 2023 05 15; 29(10):1916-1928. Bidkar AP, Wang S, Bobba KN, Chan E, Bidlingmaier S, Egusa EA, Peter R, Ali U, Meher N, Wadhwa A, Dhrona S, Dasari C, Beckford-Vera D, Su Y, Tang R, Zhang L, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Chou J, Liu B, Flavell RR. PMID: 36917693; PMCID: PMC10183825.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    25. Prediction of Weight Loss to Decrease the Risk for Type 2 Diabetes Using Multidimensional Data in Filipino Americans: Secondary Analysis. JMIR Diabetes. 2023 Apr 11; 8:e44018. Chang L, Fukuoka Y, Aouizerat BE, Zhang L, Flowers E. PMID: 37040172; PMCID: PMC10131631.
      View in: PubMed   Mentions:
    26. Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time. J Neuroendocrinol. 2023 04; 35(4):e13260. Wang SJ, Whitman J, Paciorek A, Le BK, Nakakura EK, Behr SC, Joseph N, Zhang L, Hope TA, Bergsland EK. PMID: 37002881.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma. J Sex Med. 2023 03 31; 20(4):439-446. Savoie MB, Paciorek A, Van Loon K, Anwar M, Atreya CE, Johnson PC, Kenfield SA, Laffan A, Levin AO, Smith JF, Stanfield D, Venook A, Zhang L, Van Blarigan EL, Rowen T. PMID: 36805959; PMCID: PMC10078939.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Urinary Neuroendocrine Neoplasms Treated in the "Modern Era": A Multicenter Retrospective Review. Clin Genitourin Cancer. 2023 06; 21(3):403-414.e5. Le BK, McGarrah P, Paciorek A, Mohamed A, Apolo AB, Chan DL, Reidy-Lagunes D, Hauser H, Rivero JD, Whitman J, Batty K, Zhang L, Raj N, Le T, Bergsland E, Halfdanarson TR. PMID: 37031047.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Exhausted intratumoral Vδ2- γδ T cells in human kidney cancer retain effector function. Nat Immunol. 2023 04; 24(4):612-624. Rancan C, Arias-Badia M, Dogra P, Chen B, Aran D, Yang H, Luong D, Ilano A, Li J, Chang H, Kwek SS, Zhang L, Lanier LL, Meng MV, Farber DL, Fong L. PMID: 36928415; PMCID: PMC10063448.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    30. What referring clinicians value most: Accuracy of radiology results and personal interactions with radiologists. Clin Imaging. 2023 May; 97:72-77. Haas BM, Zhang L, Nichols H, Orwig N, Hess CP, Kolli KP. PMID: 36907042.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Quality of life among colorectal cancer survivors participating in a pilot randomized controlled trial of a web-based dietary intervention with text messages. Support Care Cancer. 2023 Feb 10; 31(3):155. Wang L, Langlais C, Kenfield SA, Van Loon K, Laffan A, Atreya CE, Chan JM, Zhang L, Allen IE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP, Van Blarigan EL. PMID: 36763183; PMCID: PMC9918568.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry. Blood Adv. 2023 01 24; 7(2):269-279. Schwab ME, Lianoglou BR, Gano D, Gonzalez Velez J, Allen IE, Arvon R, Baschat A, Bianchi DW, Bitanga M, Bourguignon A, Brown RN, Chen B, Chien M, Davis-Nelson S, de Laat MWM, Ekwattanakit S, Gollin Y, Hirata G, Jelin A, Jolley J, Meyer P, Miller J, Norton ME, Ogasawara KK, Panchalee T, Schindewolf E, Shaw SW, Stumbaugh T, Thompson AA, Towner D, Tsai PS, Viprakasit V, Volanakis E, Zhang L, Vichinsky E, MacKenzie TC. PMID: 36306387; PMCID: PMC9860434.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Endorsement of a single-item measure of sleep disturbance during pregnancy and risk for postpartum depression: a retrospective cohort study. Arch Womens Ment Health. 2023 02; 26(1):67-74. Felder JN, Roubinov D, Zhang L, Gray M, Beck A. PMID: 36633715; PMCID: PMC9908713.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II). Contemp Clin Trials. 2023 02; 125:107079. Van Blarigan EL, Chan JM, Sanchez A, Zhang L, Winters-Stone K, Liu V, Macaire G, Panchal N, Graff RE, Tenggara I, Luke A, Simko JP, Cooperberg MR, Carroll PR, Kenfield SA. PMID: 36621597.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    35. Prediction Performance of Feature Selectors and Classifiers on Highly Dimensional Transcriptomic Data for Prediction of Weight Loss in Filipino Americans at Risk for Type 2 Diabetes. Biol Res Nurs. 2023 07; 25(3):393-403. Chang L, Fukuoka Y, Aouizerat BE, Zhang L, Flowers E. PMID: 36600204; PMCID: PMC10404908.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    36. Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma. J Immunother Cancer. 2023 01; 11(1). Sinha M, Betts C, Zhang L, Griffith MJ, Solman I, Chen B, Liu E, Tamaki W, Stultz J, Marquez J, Sivagnanam S, Cheung A, Pener D, Fahlman A, Taber E, Lerner K, Crocker M, Todd K, Rajagopalan B, Ware C, Bridge M, Vo J, Dragomanovich H, Sudduth-Klinger J, Vaccaro G, Lopez CD, Tempero M, Coussens LM, Fong L. PMID: 36593070; PMCID: PMC9809229.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    37. Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention. Urol Oncol. 2023 03; 41(3):146.e1-146.e11. Langlais CS, Chen YH, Van Blarigan EL, Chan JM, Ryan CJ, Zhang L, Borno HT, Newton RU, Luke A, Bang AS, Panchal N, Tenggara I, Schultz B, Lavaki E, Pinto N, Aggarwal R, Friedlander T, Koshkin VS, Harzstark AL, Small EJ, Kenfield SA. PMID: 36528473.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Evaluation of Human Epidermal Growth Factor Receptor 2 Expression in Gastric and Gastroesophageal Cancers in Tanzania. Arch Pathol Lab Med. 2022 12 01; 146(12):1523-1529. Ngaiza A, Vuhahula E, Yahaya J, Ndayisaba MC, Kawishe GJ, Grenert JP, Zhang L, Van Loon K, Ng DL. PMID: 35344993; PMCID: PMC9515243.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial. Contemp Clin Trials. 2022 Nov; 122:106941. Schoeps VA, Graves JS, Stern WA, Zhang L, Nourbakhsh B, Mowry EM, Henry RG, Waubant E. PMID: 36182028.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    40. Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis. Cell Rep. 2022 09 20; 40(12):111384. Keenan BP, McCarthy EE, Ilano A, Yang H, Zhang L, Allaire K, Fan Z, Li T, Lee DS, Sun Y, Cheung A, Luong D, Chang H, Chen B, Marquez J, Sheldon B, Kelley RK, Ye CJ, Fong L. PMID: 36130508; PMCID: PMC10060099.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    41. Investigating attitudes toward prenatal diagnosis and fetal therapy for spinal muscular atrophy. Prenat Diagn. 2022 10; 42(11):1409-1419. Schwab ME, Shao S, Zhang L, Lianoglou B, Belter L, Jarecki J, Schroth M, Sumner CJ, MacKenzie T. PMID: 36029101; PMCID: PMC10128916.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease. Clin Cancer Res. 2022 07 15; 28(14):3066-3075. Zhao N, Chopra S, Trepka K, Wang YH, Sakhamuri S, Hooshdaran N, Kim H, Zhou J, Lim SA, Leung KK, Egusa EA, Zhu J, Zhang L, Foye A, Sriram R, Chan E, Seo Y, Feng FY, Small EJ, Chou J, Wells JA, Aggarwal R, Evans MJ. PMID: 35604681; PMCID: PMC9288514.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    43. Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked dataset. Urol Oncol. 2022 08; 40(8):379.e17-379.e24. Kwon DH, Kwon DH, Paciorek A, Zhang L, Borno HT, Bucknor M, Small EJ, Aggarwal RR. PMID: 35750560.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial. Fertil Steril. 2022 Aug; 118(2):266-278. Anaya Y, Cakmak H, Mata DA, Letourneau J, Zhang L, Lenhart N, Juarez-Hernandez F, Jalalian L, Cedars MI, Rosen M. PMID: 35705380.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    45. Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study. JCO Clin Cancer Inform. 2022 05; 6:e2100182. Borno HT, Zhang L, Zhang S, Kaplan C, Palmer NR, Bell A, Bakke B, Lin A, Aggarwal R, Small EJ. PMID: 35584338; PMCID: PMC9173564.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Novel Ensemble Feature Selection Approach and Application in Repertoire Sequencing Data. Front Genet. 2022; 13:821832. He T, Baik JM, Kato C, Yang H, Fan Z, Cham J, Zhang L. PMID: 35559031; PMCID: PMC9086194.
      View in: PubMed   Mentions:
    47. A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1531-1539. de Kouchkovsky I, Rao A, Carneiro BA, Zhang L, Lewis C, Phone A, Small EJ, Friedlander T, Fong L, Paris PL, Ryan CJ, Szmulewitz RZ, Aggarwal R. PMID: 35176163.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    48. Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease. Neurology. 2022 05 31; 98(22):e2194-e2203. Bock MA, Brown EG, Zhang L, Tanner C. PMID: 35418456; PMCID: PMC9162165.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    49. The Role of Racial and Ethnic Factors in MicroRNA Expression and Risk for Type 2 Diabetes. Front Genet. 2022; 13:853633. Flowers E, Kanaya AM, Zhang L, Aouizerat BE. PMID: 35368704; PMCID: PMC8971619.
      View in: PubMed   Mentions: 6  
    50. APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer. Front Oncol. 2022; 12:816706. Natesan D, Zhang L, Martell HJ, Jindal T, Devine P, Stohr B, Espinosa-Mendez C, Grenert J, Van Ziffle J, Joseph N, Umetsu S, Onodera C, Turski M, Chan E, Desai A, Aggarwal R, Wong A, Porten S, Chou J, Friedlander T, Fong L, Small EJ, Sweet-Cordero A, Koshkin VS. PMID: 35321431; PMCID: PMC8935010.
      View in: PubMed   Mentions: 5  
    51. Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial. JCO Oncol Pract. 2022 06; 18(6):e915-e924. Borno HT, Zhang L, Zhang S, Lin TK, Skafel A, Nieves E, Dornsife D, Johnson R, Rhoads K, Small E, Spicer D. PMID: 35196064; PMCID: PMC9191303.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    52. Quality of life of colorectal cancer survivors participating in a pilot randomized controlled trial of physical activity trackers and daily text messages. Support Care Cancer. 2022 May; 30(5):4557-4564. Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya C, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP, Van Blarigan EL. PMID: 35119520; PMCID: PMC8942969.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. Risk Factors Associated With Early-Onset Esophageal Cancer in Tanzania. JCO Glob Oncol. 2022 02; 8:e2100256. Buckle GC, Mmbaga EJ, Paciorek A, Akoko L, Deardorff K, Mgisha W, Mushi BP, Mwaiselage J, Hiatt RA, Zhang L, Van Loon K. PMID: 35113655; PMCID: PMC8853620.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study. BMC Cancer. 2022 Jan 19; 22(1):82. Buckle GC, Mrema A, Mwachiro M, Ringo Y, Selekwa M, Mulima G, Some FF, Mmbaga BT, Mody GN, Zhang L, Paciorek A, Akoko L, Ayuo P, Burgert S, Bukusi E, Charles A, Chepkemoi W, Chesumbai G, Kaimila B, Kenseko A, Kibwana KS, Koech D, Macharia C, Moirana EN, Mushi BP, Mremi A, Mwaiselage J, Mwanga A, Ndumbalo J, Nvakunga G, Ngoma M, Oduor M, Oloo M, Opakas J, Parker R, Seno S, Salima A, Servent F, Wandera A, Westmoreland KD, White RE, Williams B, Mmbaga EJ, Van Loon K, of the African Esophageal Cancer Consortium (AfrECC). PMID: 35045815; PMCID: PMC8772224.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    55. Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II). JMIR Cancer. 2022 Jan 11; 8(1):e31576. Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K. PMID: 35014958; PMCID: PMC8790683.
      View in: PubMed   Mentions: 5  
    56. Characteristics and Growth Rate of Lung Metastases in Patients With Primary Gastrointestinal Malignancies and Lung-dominant Metastatic Disease: A Retrospective Cohort Analysis. Am J Clin Oncol. 2022 01 01; 45(1):22-27. Burns S, Vella M, Paciorek A, Zhang L, Atreya CE, Feng M, Kelley RK, Tempero MA, Van Loon K, Ko AH. PMID: 34864778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Expedited evaluation for liver transplantation: A critical look at processes and outcomes. Clin Transplant. 2022 03; 36(3):e14539. Braun HJ, Mello A, Kothari R, Ku E, Yilma M, Tavakol M, Zhang L, Niemann CU, Ascher NL, Adelmann D. PMID: 34791697; PMCID: PMC8898283.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer. JAMA Oncol. 2021 Nov 01; 7(11):1644-1652. Aggarwal R, Rydzewski NR, Zhang L, Foye A, Kim W, Helzer KT, Bakhtiar H, Chang SL, Perry MD, Gleave M, Reiter RE, Huang J, Evans CP, Alumkal JJ, Lang JM, Yu M, Quigley DA, Sjöström M, Small EJ, Feng FY, Zhao SG. PMID: 34554200; PMCID: PMC8461554.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    59. Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer. Cancer Med. 2021 11; 10(22):8058-8070. Kenfield SA, Van Blarigan EL, Panchal N, Bang A, Zhang L, Graff RE, Chen YH, Ryan CJ, Luke A, Newton RU, Tenggara I, Schultz B, Wang E, Lavaki E, Zuniga K, Pinto N, Borno H, Aggarwal R, Friedlander T, Koshkin VS, Harzstark A, Small E, Chan JM. PMID: 34636156; PMCID: PMC8607248.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    60. A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study. Urol Oncol. 2021 10; 39(10):730.e9-730.e15. Pollock Y, Zhang L, Kenfield SA, Van Blarigan EL, Rodvelt T, Rabow M, Macaire G, Weinberg R, Topp K, Friedlander T, Lin A, Fong L, Kim W, Ma B, Hough J, Lee M, Paciorek A, Ryan CJ, Chan JM, Small E, Aggarwal R. PMID: 34304981.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    61. Evaluating Estrogen Receptor Immunohistochemistry on Cell Blocks From Breast Cancer Patients in a Low-Resource Setting. Arch Pathol Lab Med. 2021 07 01; 145(7):834-841. Kimambo AH, Vuhahula EA, Mwakigonja AR, Ljung BM, Zhang L, Van Loon K, Ng DL. PMID: 33053150; PMCID: PMC9124437.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Sensitivity of the Unruptured Intracranial Aneurysm Treatment Score (UIATS) in the Elderly: Retrospective Analysis of Ruptured Aneurysms. World Neurosurg. 2021 08; 152:e673-e677. Rutledge C, Raper DMS, Jonzzon S, Raygor KP, Pereira MP, Winkler EA, Zhang L, Lawton MT, Abla AA. PMID: 34129975.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    63. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer. 2021 05; 9(5). de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. PMID: 33980590; PMCID: PMC8118032.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    64. Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer. J Immunother Cancer. 2021 05; 9(5). Sinha M, Zhang L, Subudhi S, Chen B, Marquez J, Liu EV, Allaire K, Cheung A, Ng S, Nguyen C, Friedlander TW, Aggarwal R, Spitzer M, Allison JP, Small EJ, Sharma P, Fong L. PMID: 33986125; PMCID: PMC8126308.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    65. Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database. Pancreas. 2021 04 01; 50(4):506-512. Chan H, Zhang L, Choti MA, Kulke M, Yao JC, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR, Bergsland EK, Van Loon K. PMID: 33939661; PMCID: PMC8097723.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy. J Immunol Methods. 2021 07; 494:113041. Zhang L, Cham J, Cooley J, He T, Hagihara K, Yang H, Fan F, Cheung A, Thompson D, Kerns BJ, Fong L. PMID: 33753096.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    67. Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer. Cancer. 2021 06 15; 127(12):1965-1973. Kwon DH, Chou J, Yip SM, Reimers MA, Zhang L, Wright F, Dhawan MS, Borno HT, Desai A, Aggarwal RR, Wyatt AW, Small EJ, Alva AS, Chi KN, Feng FY, Koshkin VS. PMID: 33690902.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    68. Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients. Cancer Immunol Immunother. 2021 Jul; 70(7):2095-2102. Naidus E, Bouquet J, Oh DY, Looney TJ, Yang H, Fong L, Standifer NE, Zhang L. PMID: 33420629; PMCID: PMC8195930.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    69. A Case-Control Study to Evaluate Environmental and Lifestyle Risk Factors for Esophageal Cancer in Tanzania. Cancer Epidemiol Biomarkers Prev. 2021 02; 30(2):305-316. Mmbaga EJ, Mushi BP, Deardorff K, Mgisha W, Akoko LO, Paciorek A, Hiatt RA, Buckle GC, Mwaiselage J, Zhang L, Van Loon K. PMID: 33144280.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    70. The Association Between Vena Cava Implantation Technique and Acute Kidney Injury After Liver Transplantation. Transplantation. 2020 11; 104(11):e308-e316. Hannon V, Kothari RP, Zhang L, Bokoch MP, Hill R, Roll GR, Mello A, Feiner JR, Liu KD, Niemann CU, Adelmann D. PMID: 32467477.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    71. Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T. Cancer Immunol Res. 2020 12; 8(12):1496-1507. Zhang L, Kandadi H, Yang H, Cham J, He T, Oh DY, Sheikh NA, Fong L. PMID: 32967912; PMCID: PMC7903967.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    72. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology. 2020 12 15; 95(24):e3203-e3212. Guterman EL, Sanford JK, Betjemann JP, Zhang L, Burke JF, Lowenstein DH, Josephson SA, Sporer KA. PMID: 32943481; PMCID: PMC7836670.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    73. The DNA methylation landscape of advanced prostate cancer. Nat Genet. 2020 08; 52(8):778-789. Zhao SG, Chen WS, Li H, Foye A, Zhang M, Sjöström M, Aggarwal R, Playdle D, Liao A, Alumkal JJ, Das R, Chou J, Hua JT, Barnard TJ, Bailey AM, Chow ED, Perry MD, Dang HX, Yang R, Moussavi-Baygi R, Zhang L, Alshalalfa M, Laura Chang S, Houlahan KE, Shiah YJ, Beer TM, Thomas G, Chi KN, Gleave M, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Yvonne Kim M, Fong L, Spratt DE, Morgan TM, Bose R, Huang FW, Li H, Chesner L, Shenoy T, Goodarzi H, Asangani IA, Sandhu S, Lang JM, Mahajan NP, Lara PN, Evans CP, Febbo P, Batzoglou S, Knudsen KE, He HH, Huang J, Zwart W, Costello JF, Luo J, Tomlins SA, Wyatt AW, Dehm SM, Ashworth A, Gilbert LA, Boutros PC, Farh K, Chinnaiyan AM, Maher CA, Small EJ, Quigley DA, Feng FY. PMID: 32661416; PMCID: PMC7454228.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansCells
    74. Fecal Immunologic Test Results and Diagnostic Colonoscopy in a Mexican Population at Average Risk for Colorectal Cancer. Cancer Prev Res (Phila). 2020 11; 13(11):959-966. Manzano-Robleda MDC, Espinosa-Tamez P, Potter MB, Lajous M, Van Loon K, Zhang L, Jimenez-Peña A, Sánchez Del Monte J, Mohar A, Hernández-Guerrero A. PMID: 32655008.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer. Urol Oncol. 2020 12; 38(12):931.e9-931.e16. Kwon DH, Zhang L, Quigley DA, Foye A, Chen WS, Wong CK, Feng FY, Bailey A, Huang J, Stuart JM, Friedl V, Weinstein AS, Beer TM, Alumkal JJ, Rettig M, Gleave M, Lara PN, Thomas GV, Li P, Lui A, Small EJ, Aggarwal RR. PMID: 32624423.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    76. Impact of Anesthesia on Long-term Outcomes in Patients With Supratentorial High-grade Glioma Undergoing Tumor Resection: A Retrospective Cohort Study. J Neurosurg Anesthesiol. 2020 Jul; 32(3):227-233. Dong J, Zeng M, Ji N, Hao S, Zhou Y, Gao Z, Gu H, Zhang L, Ma D, Peng Y, Han R. PMID: 30807485.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    77. Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors. J Nucl Med. 2021 02; 62(2):221-227. Lawhn-Heath C, Fidelman N, Chee B, Jivan S, Armstrong E, Zhang L, Lindsay S, Bergsland EK, Hope TA. PMID: 32513903.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    78. Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies. J Immunother Cancer. 2020 05; 8(1). Cham J, Zhang L, Kwek S, Paciorek A, He T, Fong G, Oh DY, Fong L. PMID: 32376721; PMCID: PMC7223469.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    79. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Prostate. 2020 05; 80(8):653-659. Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP. PMID: 32220141.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    80. The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer. J Racial Ethn Health Disparities. 2020 10; 7(5):996-1002. Zuniga KB, Borno H, Chan JM, Van Blarigan EL, Friedlander TW, Wang S, Zhang L, Kenfield SA. PMID: 32078741; PMCID: PMC8567804.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    81. Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer. Oncologist. 2020 07; 25(7):564-571. Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K. PMID: 32031306; PMCID: PMC7356671.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    82. Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):752-760. Van Blarigan EL, Kenfield SA, Chan JM, Van Loon K, Paciorek A, Zhang L, Chan H, Savoie MB, Bocobo AG, Liu VN, Wong LX, Laffan A, Atreya CE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP. PMID: 31941707; PMCID: PMC7125029.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    83. TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer. Front Immunol. 2019; 10:2985. Looney TJ, Topacio-Hall D, Lowman G, Conroy J, Morrison C, Oh D, Fong L, Zhang L. PMID: 31993050; PMCID: PMC6962348.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    84. Choice of ANesthesia for EndoVAScular Treatment of Acute Ischemic Stroke (CANVAS): Results of the CANVAS Pilot Randomized Controlled Trial. J Neurosurg Anesthesiol. 2020 Jan; 32(1):41-47. Sun J, Liang F, Wu Y, Zhao Y, Miao Z, Zhang L, Gelb AW, Chan MTV, Peng Y, Han R, CANVAS Pilot Trial Investigators. PMID: 30531556.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    85. Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses. Cancer Immunol Res. 2020 02; 8(2):246-254. Greaney SK, Algazi AP, Tsai KK, Takamura KT, Chen L, Twitty CG, Zhang L, Paciorek A, Pierce RH, Le MH, Daud AI, Fong L. PMID: 31852717; PMCID: PMC7002232.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    86. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation. J Gastrointest Cancer. 2019 Dec; 50(4):769-779. Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K. PMID: 30058032; PMCID: PMC6650370.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    87. How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials. Contemp Clin Trials Commun. 2019 Dec; 16:100476. Borno HT, Small EJ, Zhang L, DeRouen MC, Griffin A, McGuire J, Ryan CJ, Hiatt RA, Kaplan CP. PMID: 31872154; PMCID: PMC6915794.
      View in: PubMed   Mentions: 6  
    88. Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer. Eur Urol. 2020 03; 77(3):333-341. Reimers MA, Yip SM, Zhang L, Cieslik M, Dhawan M, Montgomery B, Wyatt AW, Chi KN, Small EJ, Chinnaiyan AM, Alva AS, Feng FY, Chou J. PMID: 31640893; PMCID: PMC7365609.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    89. A Simple Approximation to Bias in Gene-Environment Interaction Estimates When a Case Might Not Be the Case. Front Genet. 2019; 10:886. Lobach I, Kim I, Alekseyenko A, Lobach S, Zhang L. PMID: 31681402; PMCID: PMC6812609.
      View in: PubMed   Mentions:
    90. Correlation of DOTATOC Uptake and Pathologic Grade in Neuroendocrine Tumors. Pancreas. 2019 08; 48(7):948-952. Chan H, Moseley C, Zhang L, Bergsland EK, Pampaloni MH, Van Loon K, Hope TA. PMID: 31268975.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    91. Vitamin D Levels in Patients with Colorectal Cancer and Matched Household Members. J Clin Nutr Food Sci. 2019; 2. Savoie MB, Paciorek A, Zhang L, Sommovilla N, Venook AP, Van Blarigan EL, Van Loon K. PMID: 31423489; PMCID: PMC6697376.
      View in: PubMed   Mentions:
    92. Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer. J Urol. 2019 07; 202(1):90-95. Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP. PMID: 30810466.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    93. Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases. Pancreas. 2019 04; 48(4):496-503. Kwon DH, Paciorek A, Mulvey CK, Chan H, Fidelman N, Meng L, Nakakura EK, Zhang L, Bergsland EK, Van Loon K. PMID: 30946246.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    94. Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2019 11; 76(5):562-571. Chen WS, Aggarwal R, Zhang L, Zhao SG, Thomas GV, Beer TM, Quigley DA, Foye A, Playdle D, Huang J, Lloyd P, Lu E, Sun D, Guan X, Rettig M, Gleave M, Evans CP, Youngren J, True L, Lara P, Kothari V, Xia Z, Chi KN, Reiter RE, Maher CA, Feng FY, Small EJ, Alumkal JJ, West Coast Prostate Cancer Dream Team. PMID: 30928160; PMCID: PMC6764911.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    95. Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity. Mol Cancer Res. 2019 06; 17(6):1235-1240. Aggarwal RR, Quigley DA, Huang J, Zhang L, Beer TM, Rettig MB, Reiter RE, Gleave ME, Thomas GV, Foye A, Playdle D, Lloyd P, Chi KN, Evans CP, Lara PN, Feng FY, Alumkal JJ, Small EJ. PMID: 30918106; PMCID: PMC6548614.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    96. Attitudes and Barriers to Research Among Oncology Trainees in East Africa. Oncologist. 2019 09; 24(9):e864-e869. Rubagumya F, Nyagabona SK, Msami KH, Manirakiza A, Longombe AN, Maniragaba T, Chan H, Paciorek A, Zhang L, Balandya E, Germana LH, Mmbaga EJ, Dharsee N, Van Loon K. PMID: 30902914; PMCID: PMC6738315.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    97. A simple approximation to bias in the genetic effect estimates when multiple disease states share a clinical diagnosis. Genet Epidemiol. 2019 07; 43(5):522-531. Lobach I, Kim I, Alekseyenko A, Lobach S, Zhang L. PMID: 30888715; PMCID: PMC6559860.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    98. Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial. BMC Cancer. 2019 Mar 11; 19(1):218. Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP. PMID: 30866859; PMCID: PMC6417122.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    99. 111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden. J Nucl Med. 2019 09; 60(9):1266-1269. Hope TA, Calais J, Zhang L, Dieckmann W, Millo C. PMID: 30850506; PMCID: PMC6735279.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    100. Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade. Immunity. 2019 02 19; 50(2):477-492.e8. Pai CS, Huang JT, Lu X, Simons DM, Park C, Chang A, Tamaki W, Liu E, Roybal KT, Seagal J, Chen M, Hagihara K, Wei XX, DuPage M, Kwek SS, Oh DY, Daud A, Tsai KK, Wu C, Zhang L, Fasso M, Sachidanandam R, Jayaprakash A, Lin I, Casbon AJ, Kinsbury GA, Fong L. PMID: 30737146; PMCID: PMC6886475.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    101. Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer. Eur Urol. 2019 06; 75(6):950-958. Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM. PMID: 30638635.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    102. A simple approximation to the bias of gene-environment interactions in case-control studies with silent disease. Genet Epidemiol. 2019 04; 43(3):292-299. Lobach I, Sampson J, Lobach S, Alekseyenko A, Piryatinska A, He T, Zhang L. PMID: 30623487; PMCID: PMC6416064.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. Reply to A. Dalla Volta et al. J Clin Oncol. 2019 02 01; 37(4):351-352. Aggarwal R, Huang J, Alumkal J, Feng FY, Zhang L, Stuart JM, Small EJ. PMID: 30557523.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 2018 10 18; 175(3):889. Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, Foye A, Kothari V, Perry MD, Bailey AM, Playdle D, Barnard TJ, Zhang L, Zhang J, Youngren JF, Cieslik MP, Parolia A, Beer TM, Thomas G, Chi KN, Gleave M, Lack NA, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Ryan CJ, Fong L, Kim W, Friedlander T, Chou J, Li H, Das R, Li H, Moussavi-Baygi R, Goodarzi H, Gilbert LA, Lara PN, Evans CP, Goldstein TC, Stuart JM, Tomlins SA, Spratt DE, Cheetham RK, Cheng DT, Farh K, Gehring JS, Hakenberg J, Liao A, Febbo PG, Shon J, Sickler B, Batzoglou S, Knudsen KE, He HH, Huang J, Wyatt AW, Dehm SM, Ashworth A, Chinnaiyan AM, Maher CA, Small EJ, Feng FY. PMID: 30340047.
      View in: PubMed   Mentions: 65     Fields:    
    105. Efficacy of an Intensive, Ultrasound-Guided Fine-Needle Aspiration Biopsy Training Workshop in Tanzania. J Glob Oncol. 2018 10; 4:1-9. Ng DL, Vuhahula E, Zhang L, Waterhouse EG, White KL, Mushi BP, Nyeriga MS, Philipo GS, Mmbaga EJ, Sheth S, Van Loon K, Lee AY, Balassanian R. PMID: 30372401; PMCID: PMC7010453.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    106. Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer. Oncoimmunology. 2019; 8(1):e1486953. Hagihara K, Chan S, Zhang L, Oh DY, Wei XX, Simko J, Fong L. PMID: 30546940; PMCID: PMC6287789.
      View in: PubMed   Mentions: 14     Fields:    
    107. Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study. Clin Genitourin Cancer. 2019 Feb; 17(1):e92-e96. Lee M, Hong H, Kim W, Zhang L, Friedlander TW, Fong L, Lin AM, Small EJ, Wei XX, Rodvelt TJ, Miralda B, Stocksdale B, Ryan CJ, Aggarwal R. PMID: 30327180.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    108. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018 12; 289(3):730-737. Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. PMID: 30226456; PMCID: PMC6283324.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    109. Case-control studies of gene-environment interactions. When a case might not be the case. PLoS One. 2018; 13(8):e0201140. Lobach I, Sampson J, Alekseyenko A, Lobach S, Zhang L. PMID: 30133451; PMCID: PMC6104951.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    110. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 2018 07 26; 174(3):758-769.e9. Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, Foye A, Kothari V, Perry MD, Bailey AM, Playdle D, Barnard TJ, Zhang L, Zhang J, Youngren JF, Cieslik MP, Parolia A, Beer TM, Thomas G, Chi KN, Gleave M, Lack NA, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Ryan CJ, Fong L, Kim W, Friedlander T, Chou J, Li H, Das R, Li H, Moussavi-Baygi R, Goodarzi H, Gilbert LA, Lara PN, Evans CP, Goldstein TC, Stuart JM, Tomlins SA, Spratt DE, Cheetham RK, Cheng DT, Farh K, Gehring JS, Hakenberg J, Liao A, Febbo PG, Shon J, Sickler B, Batzoglou S, Knudsen KE, He HH, Huang J, Wyatt AW, Dehm SM, Ashworth A, Chinnaiyan AM, Maher CA, Small EJ, Feng FY. PMID: 30033370; PMCID: PMC6425931.
      View in: PubMed   Mentions: 272     Fields:    Translation:HumansCells
    111. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. J Clin Oncol. 2018 08 20; 36(24):2492-2503. Aggarwal R, Huang J, Alumkal JJ, Zhang L, Feng FY, Thomas GV, Weinstein AS, Friedl V, Zhang C, Witte ON, Lloyd P, Gleave M, Evans CP, Youngren J, Beer TM, Rettig M, Wong CK, True L, Foye A, Playdle D, Ryan CJ, Lara P, Chi KN, Uzunangelov V, Sokolov A, Newton Y, Beltran H, Demichelis F, Rubin MA, Stuart JM, Small EJ. PMID: 29985747; PMCID: PMC6366813.
      View in: PubMed   Mentions: 312     Fields:    Translation:HumansCellsCTClinical Trials
    112. Gene-environment interactions in case-control studies with silent disease. Genet Epidemiol. 2018 09; 42(6):551-558. Lobach I, Sampson J, Lobach S, Zhang L. PMID: 29896809; PMCID: PMC6237277.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    113. Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol. BMJ Open. 2018 05 14; 8(5):e022899. Newton RU, Kenfield SA, Hart NH, Chan JM, Courneya KS, Catto J, Finn SP, Greenwood R, Hughes DC, Mucci L, Plymate SR, Praet SFE, Guinan EM, Van Blarigan EL, Casey O, Buzza M, Gledhill S, Zhang L, Galvão DA, Ryan CJ, Saad F. PMID: 29764892; PMCID: PMC5961562.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    114. At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials. Oncologist. 2018 10; 23(10):1242-1249. Borno HT, Zhang L, Siegel A, Chang E, Ryan CJ. PMID: 29700209; PMCID: PMC6263122.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    115. A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone- and/or Enzalutamide-Refractory Metastatic Castration-Resistant Prostate Cancer. Oncologist. 2018 06; 23(6):656-e64. Wei XX, Siegel AP, Aggarwal R, Lin AM, Friedlander TW, Fong L, Kim W, Louttit M, Chang E, Zhang L, Ryan CJ. PMID: 29487219; PMCID: PMC6067936.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    116. Revealing nascent proteomics in signaling pathways and cell differentiation. Proc Natl Acad Sci U S A. 2018 03 06; 115(10):2353-2358. Forester CM, Zhao Q, Phillips NJ, Urisman A, Chalkley RJ, Oses-Prieto JA, Zhang L, Ruggero D, Burlingame AL. PMID: 29467287; PMCID: PMC5877968.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    117. Clinical Variables Associated With Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Sipuleucel-T Immunotherapy. Clin Genitourin Cancer. 2018 06; 16(3):184-190.e2. Wei XX, Perry J, Chang E, Zhang L, Hiatt RA, Ryan CJ, Small EJ, Fong L. PMID: 29352713.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    118. High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer. Clin Genitourin Cancer. 2017 12; 15(6):733-741.e1. Friedlander TW, Graff JN, Zejnullahu K, Anantharaman A, Zhang L, Paz R, Premasekharan G, Russell C, Huang Y, Kim W, Aggarwal RR, Lin AM, Fong L, Alumkal JJ, Beer TM, Sharifi N, Alyamani M, Dittamore R, Small EJ, Paris PL, Ryan CJ. PMID: 28655452.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    119. Characteristics of Esophageal Cancer Cases in Tanzania. J Glob Oncol. 2018 09; 4:1-10. Mmbaga EJ, Deardorff KV, Mushi B, Mgisha W, Merritt M, Hiatt RA, Mwaiselage J, Zhang L, Van Loon K. PMID: 30241222; PMCID: PMC6180793.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    120. Choice of ANesthesia for EndoVAScular Treatment of Acute Ischemic Stroke: Protocol for a randomized controlled (CANVAS) trial. Int J Stroke. 2017 12; 12(9):991-997. Peng Y, Li Y, Jian M, Liu X, Sun J, Jia B, Dong J, Zeng M, Lin N, Zhang L, Gelb AW, Chan MT, Han R. PMID: 28436307.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    121. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data. BMC Bioinformatics. 2017 Feb 27; 18(1):129. Zhang L, Cham J, Paciorek A, Trager J, Sheikh N, Fong L. PMID: 28241742; PMCID: PMC5327583.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    122. A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study. Urol Oncol. 2017 04; 35(4):149.e7-149.e13. Aggarwal R, Bryce A, Ryan CJ, Harzstark A, Derleth C, Kim W, Friedlander T, Lin AM, Rodvelt-Bagchi T, Dhawan M, Zhang L, Lee M, Siebeneck E, Hough J, Small EJ. PMID: 28161323.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    123. Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire. Cancer Res. 2017 03 15; 77(6):1322-1330. Oh DY, Cham J, Zhang L, Fong G, Kwek SS, Klinger M, Faham M, Fong L. PMID: 28031229; PMCID: PMC5398199.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCells
    124. Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunol Res. 2016 11; 4(11):948-958. Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L. PMID: 27688020; PMCID: PMC5115633.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    125. Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):e109-e116. Zhang L, Johnson J, Gottschalk AR, Chang AJ, Hsu IC, Roach M, Seymour ZA. PMID: 28274401.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    126. Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects. Cancer Res. 2016 07 01; 76(13):3711-8. Sheikh N, Cham J, Zhang L, DeVries T, Letarte S, Pufnock J, Hamm D, Trager J, Fong L. PMID: 27216195.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCellsCTClinical Trials
    127. GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses. Oncoimmunology. 2016 Apr; 5(4):e1101204. Kwek SS, Kahn J, Greaney SK, Lewis J, Cha E, Zhang L, Weber RW, Leonard L, Markovic SN, Fong L, Spitler LE. PMID: 27141383; PMCID: PMC4839354.
      View in: PubMed   Mentions: 19     Fields:    
    128. Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab. Cancer Immunol Res. 2015 Sep; 3(9):1008-16. Kwek SS, Lewis J, Zhang L, Weinberg V, Greaney SK, Harzstark AL, Lin AM, Ryan CJ, Small EJ, Fong L. PMID: 25968455; PMCID: PMC4561203.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCellsCTClinical Trials
    129. The interface of inflammation and subclinical atherosclerosis in granulomatosis with polyangiitis (Wegener's): a preliminary study. Transl Res. 2015 Oct; 166(4):366-74. Hajj-Ali RA, Major J, Langford C, Hoffman GS, Clark T, Zhang L, Sun Z, Silverstein RL. PMID: 26024800; PMCID: PMC4862201.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    130. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e465-e472. Seymour ZA, Chang AJ, Zhang L, Kirby N, Descovich M, Roach M, Hsu IC, Gottschalk AR. PMID: 25795252.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    131. The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot? Cancer Epidemiol. 2015 Apr; 39(2):143-9. Cheng ML, Zhang L, Borok M, Chokunonga E, Dzamamala C, Korir A, Wabinga HR, Hiatt RA, Parkin DM, Van Loon K. PMID: 25662402; PMCID: PMC4470609.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    132. Somatic wiskott-aldrich syndrome protein family member 3 (WASF3) mutations in myelodysplastic syndromes and related myeloid malignancies. Leukemia Research. 2015; 39:S85-S86. V. Visconte, A. Tabarroki, L. Zhang, A.T. Gerds, H.J. Rogers, Y. Han, J. Barnard, V. Shivarov, J. Carew, R.V. Tiu .
    133. Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts. J Hematol Oncol. 2014 Dec 07; 7:89. Visconte V, Tabarroki A, Zhang L, Parker Y, Hasrouni E, Mahfouz R, Isono K, Koseki H, Sekeres MA, Saunthararajah Y, Barnard J, Lindner D, Rogers HJ, Tiu RV. PMID: 25481243; PMCID: PMC4266210.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    134. Bone metastases and skeletal-related events from neuroendocrine tumors. Endocr Connect. 2015 Mar; 4(1):9-17. Van Loon K, Zhang L, Keiser J, Carrasco C, Glass K, Ramirez MT, Bobiak S, Nakakura EK, Venook AP, Shah MH, Bergsland EK. PMID: 25430999; PMCID: PMC4285767.
      View in: PubMed   Mentions: 35  
    135. Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens. Clin Cancer Res. 2014 Dec 15; 20(24):6269-76. Kim W, Zhang L, Wilton JH, Fetterly G, Mohler JL, Weinberg V, Morse A, Szmulewitz RZ, Friedlander TW, Fong L, Lin AM, Harzstark AL, Molina A, Small EJ, Ryan CJ. PMID: 25336698; PMCID: PMC4277885.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    136. Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10). Am J Hematol. 2014 Aug; 89(8):862. Visconte V, Tabarroki A, Zhang L, Hasrouni E, Gerace C, Frum R, Ai J, Advani AS, Duong HK, Kalaycio M, Saunthararajah Y, Sekeres MA, His ED, Shetty S, Rogers HJ, Tiu RV. PMID: 24796269.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    137. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy. Thromb Res. 2014 Jul; 134(1):96-104. Timur AA, Murugesan G, Zhang L, Barnard J, Bhatt DL, Kottke-Marchant K. PMID: 24852729; PMCID: PMC4097303.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    138. Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. Am J Hum Genet. 2014 Mar 06; 94(3):349-60. Tragante V, Barnes MR, Ganesh SK, Lanktree MB, Guo W, Franceschini N, Smith EN, Johnson T, Holmes MV, Padmanabhan S, Karczewski KJ, Almoguera B, Barnard J, Baumert J, Chang YP, Elbers CC, Farrall M, Fischer ME, Gaunt TR, Gho JM, Gieger C, Goel A, Gong Y, Isaacs A, Kleber ME, Mateo Leach I, McDonough CW, Meijs MF, Melander O, Nelson CP, Nolte IM, Pankratz N, Price TS, Shaffer J, Shah S, Tomaszewski M, van der Most PJ, Van Iperen EP, Vonk JM, Witkowska K, Wong CO, Zhang L, Beitelshees AL, Berenson GS, Bhatt DL, Brown M, Burt A, Cooper-DeHoff RM, Connell JM, Cruickshanks KJ, Curtis SP, Davey-Smith G, Delles C, Gansevoort RT, Guo X, Haiqing S, Hastie CE, Hofker MH, Hovingh GK, Kim DS, Kirkland SA, Klein BE, Klein R, Li YR, Maiwald S, Newton-Cheh C, O'Brien ET, Onland-Moret NC, Palmas W, Parsa A, Penninx BW, Pettinger M, Vasan RS, Ranchalis JE, M Ridker P, Rose LM, Sever P, Shimbo D, Steele L, Stolk RP, Thorand B, Trip MD, van Duijn CM, Verschuren WM, Wijmenga C, Wyatt S, Young JH, Zwinderman AH, Bezzina CR, Boerwinkle E, Casas JP, Caulfield MJ, Chakravarti A, Chasman DI, Davidson KW, Doevendans PA, Dominiczak AF, FitzGerald GA, Gums JG, Fornage M, Hakonarson H, Halder I, Hillege HL, Illig T, Jarvik GP, Johnson JA, Kastelein JJ, Koenig W, Kumari M, März W, Murray SS, O'Connell JR, Oldehinkel AJ, Pankow JS, Rader DJ, Redline S, Reilly MP, Schadt EE, Kottke-Marchant K, Snieder H, Snyder M, Stanton AV, Tobin MD, Uitterlinden AG, van der Harst P, van der Schouw YT, Samani NJ, Watkins H, Johnson AD, Reiner AP, Zhu X, de Bakker PI, Levy D, Asselbergs FW, Munroe PB, Keating BJ. PMID: 24560520; PMCID: PMC3951943.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    139. Large Granular Lymphocytic: Common Therapies and their Outcomes. Journal of Hematology and Transfusion. 2014; (2). Manuel G. Afable II, Michael J. Clemente, Andres Jerez, Li Zhang, Holleh Husseinzadeh, Hanna Rajala, Satu Mustjoki, Hideki Makishima, Brittney E. Dienes, John Desamito, Alan Lichtin, Mikkael A. Sekeres, Brad Pohlman, Anjali Advani, Ramon V. Tiu, Jaroslaw P. Maciejewski.
    140. Management and outcomes for patients with TTP: analysis of 100 cases at a single institution. Am J Hematol. 2013 Jul; 88(7):560-5. Chaturvedi S, Carcioppolo D, Zhang L, McCrae KR. PMID: 23605996.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    141. cgaTOH: extended approach for identifying tracts of homozygosity. PLoS One. 2013; 8(3):e57772. Zhang L, Orloff MS, Reber S, Li S, Zhao Y, Eng C. PMID: 23469237; PMCID: PMC3585782.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    142. Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer. PLoS One. 2012; 7(8):e42895. Kulkarni S, Augoff K, Rivera L, McCue B, Khoury T, Groman A, Zhang L, Tian L, Sossey-Alaoui K. PMID: 22952619; PMCID: PMC3428347.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    143. Integrative genomic analysis reveals extended germline homozygosity with lung cancer risk in the PLCO cohort. PLoS One. 2012; 7(2):e31975. Orloff MS, Zhang L, Bebek G, Eng C. PMID: 22384118; PMCID: PMC3288062.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    144. Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes. Clin Cancer Res. 2012 Mar 15; 18(6):1578-87. Ashida S, Orloff MS, Bebek G, Zhang L, Zheng P, Peehl DM, Eng C. PMID: 22275508.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    145. Association of factor V gene polymorphism with arteriovenous graft failure. Am J Kidney Dis. 2012 May; 59(5):682-8. Allon M, Zhang L, Maya ID, Bray MS, Fernandez JR, Dialysis Access Consortium (DAC) Study Investigators. PMID: 22281051; PMCID: PMC3328616.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    146. Modeling haplotype-haplotype interactions in case-control genetic association studies. Front Genet. 2012; 3:2. Zhang L, Liu R, Wang Z, Culver DA, Wu R. PMID: 22303409; PMCID: PMC3260479.
      View in: PubMed   Mentions: 8  
    147. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood. 2011 Jun 09; 117(23):6355-66. Ghosh A, Murugesan G, Chen K, Zhang L, Wang Q, Febbraio M, Anselmo RM, Marchant K, Barnard J, Silverstein RL. PMID: 21478428; PMCID: PMC3122954.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    148. Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A. 2010 Jun 22; 107(25):11459-64. Beall CM, Cavalleri GL, Deng L, Elston RC, Gao Y, Knight J, Li C, Li JC, Liang Y, McCormack M, Montgomery HE, Pan H, Robbins PA, Shianna KV, Tam SC, Tsering N, Veeramah KR, Wang W, Wangdui P, Weale ME, Xu Y, Xu Z, Yang L, Zaman MJ, Zeng C, Zhang L, Zhang X, Zhaxi P, Zheng YT. PMID: 20534544; PMCID: PMC2895075.
      View in: PubMed   Mentions: 361     Fields:    Translation:Humans
    149. Semiparametric Bayesian modeling of random genetic effects in family-based association studies. Stat Med. 2009 Jan 15; 28(1):113-39. Zhang L, Mukherjee B, Hu B, Moreno V, Cooney KA. PMID: 18792083; PMCID: PMC2684653.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    150. Accounting for error due to misclassification of exposures in case-control studies of gene-environment interaction. Stat Med. 2008 Jul 10; 27(15):2756-83. Zhang L, Mukherjee B, Ghosh M, Gruber S, Moreno V. PMID: 17879261.
      View in: PubMed   Mentions: 21     Fields:    Translation:PHPublic Health
    151. A Computational Approach to the Functional Clustering of Periodic Gene Expression Profiles. Genetics. 2008; (180):1-14. Bong-Rae Kim, Li Zhang, Arthur Berg, Jianqing Fan and Rongling Wu.
    152. Modeling Unobserved Sources of Heterogeneity in Animal Abundance using a Dirichlet Process Prior. Biometrics. 2008; 2(64):635-644. Robert Dorazio, Bhramar Mukherjee, Li Zhang, Malay Ghosh, Howard L. Jelks, and Frank Jordan.
    153. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med. 2007 Dec 20; 357(25):2543-51. Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL, Platzer P, Eng C. PMID: 18094375.
      View in: PubMed   Mentions: 140     Fields:    Translation:HumansCells
    154. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. JAMA. 2007 Jan 10; 297(2):187-95. Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P, Eng C. PMID: 17213402.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    155. Semiparametric Bayesian Analysis of Case-Control Data under Conditional Gene-Environment Independence. Biometrics. 2007; (63):834-844. Bhramar Mukherjee, Li Zhang, Malay Ghosh and Samiran Sinha.
    156. A Bayesian Framework for Genetic Association in Case-Control Studies: Accounting for Unknown Population Substructure. Statistical Modeling. 2006; (6):352-372. Li Zhang, Bhramar Mukherjee, Malay Ghosh and Rongling Wu.
    157. Equivalence of Posteriors in the Bayesian Analysis of The Multinomial-Poisson Transformation. Metron - International Journal of Statistics. 2006; 1(LXIV):19-28. Malay Ghosh, Li Zhang and Bhramar Mukherjee. .
    158. A model for estimating joint maternal-offspring effects on seed development in autogamous plants. Physiol Genomics. 2004 Nov 17; 19(3):262-9. Zhang L, Yang MC, Wang X, Larkins BA, Gallo-Meagher M, Wu R. PMID: 15548832.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    Li's Networks
    Concepts (566)
    Derived automatically from this person's publications.
    _
    Co-Authors (232)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _